Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 82

1.

Impact of intraoperative rupture of the ovarian capsule on prognosis in patients with early-stage epithelial ovarian cancer: a meta-analysis.

Kim HS, Ahn JH, Chung HH, Kim JW, Park NH, Song YS, Lee HP, Kim YB.

Eur J Surg Oncol. 2013 Mar;39(3):279-89. doi: 10.1016/j.ejso.2012.12.003. Epub 2012 Dec 27.

PMID:
23273873
2.

Influence of intraoperative capsule rupture on outcomes in stage I epithelial ovarian cancer.

Bakkum-Gamez JN, Richardson DL, Seamon LG, Aletti GD, Powless CA, Keeney GL, O'Malley DM, Cliby WA.

Obstet Gynecol. 2009 Jan;113(1):11-7. doi: 10.1097/AOG.0b013e3181917a0c.

PMID:
19104354
3.

The clinical value of surgeons' efforts of preventing intraoperative tumor rupture in stage I clear cell carcinoma of the ovary: A Korean multicenter study.

Suh DH, Park JY, Lee JY, Kim BG, Lim MC, Kim JW, Bae DS, Park SY, Nam JH, Kim K, No JH, Kim YB.

Gynecol Oncol. 2015 Jun;137(3):412-7. doi: 10.1016/j.ygyno.2015.03.058. Epub 2015 Apr 11.

PMID:
25868967
4.

The influence of intraoperative tumor rupture on recurrence risk in Stage Ic epithelial ovarian cancer.

Goudge CS, Li Z, Downs LS Jr.

Eur J Gynaecol Oncol. 2009;30(1):25-8.

PMID:
19317252
5.

Improved 5-year disease-free survival for FIGO stage I epithelial ovarian cancer patients without tumor rupture during surgery.

Paulsen T, Kærn J, Tropé C.

Gynecol Oncol. 2011 Jul;122(1):83-8. doi: 10.1016/j.ygyno.2011.02.038. Epub 2011 Mar 23.

PMID:
21435701
6.

[Re-evaluation of interval debulking surgery in advanced epithelial ovarian cancer].

Ma Y, Li Y, Cui H, Liang XD, Tang ZJ, Li XP, Zhao Y, Wei LH.

Zhonghua Fu Chan Ke Za Zhi. 2012 May;47(5):355-60. Chinese.

PMID:
22883524
7.

Survival impact of capsule rupture in stage I clear cell carcinoma of the ovary in comparison with other histological types.

Higashi M, Kajiyama H, Shibata K, Mizuno M, Mizuno K, Hosono S, Kawai M, Nakanishi T, Nagasaka T, Kikkawa F.

Gynecol Oncol. 2011 Dec;123(3):474-8. doi: 10.1016/j.ygyno.2011.08.036. Epub 2011 Sep 28.

PMID:
21955484
8.

Risk factors for lymph node metastasis in apparent early-stage epithelial ovarian cancer: implications for surgical staging.

Powless CA, Aletti GD, Bakkum-Gamez JN, Cliby WA.

Gynecol Oncol. 2011 Sep;122(3):536-40. doi: 10.1016/j.ygyno.2011.05.001. Epub 2011 Jun 1.

PMID:
21636114
9.

Intestinal surgery in treatment of advanced ovarian cancer--review of our experience.

Stefanović A, Jeremić K, Kadija S, Milincić N, Mircić A, Petković S, Zizić V.

Eur J Gynaecol Oncol. 2011;32(4):419-22.

PMID:
21941966
10.

Impact of adjuvant chemotherapy and surgical staging in early-stage ovarian carcinoma: European Organisation for Research and Treatment of Cancer-Adjuvant ChemoTherapy in Ovarian Neoplasm trial.

Trimbos JB, Vergote I, Bolis G, Vermorken JB, Mangioni C, Madronal C, Franchi M, Tateo S, Zanetta G, Scarfone G, Giurgea L, Timmers P, Coens C, Pecorelli S; EORTC-ACTION collaborators. European Organisation for Research and Treatment of Cancer-Adjuvant ChemoTherapy in Ovarian Neoplasm.

J Natl Cancer Inst. 2003 Jan 15;95(2):113-25.

PMID:
12529344
11.

Prognostic factors for high-risk early-stage epithelial ovarian cancer: a Gynecologic Oncology Group study.

Chan JK, Tian C, Monk BJ, Herzog T, Kapp DS, Bell J, Young RC; Gynecologic Oncology Group.

Cancer. 2008 May 15;112(10):2202-10. doi: 10.1002/cncr.23390.

12.

Should stage IIIC ovarian cancer be further stratified by intraperitoneal vs. retroperitoneal only disease?: a Gynecologic Oncology Group study.

Rungruang B, Miller A, Richard SD, Hamilton CA, Rodriguez N, Bookman MA, Maxwell GL, Krivak TC, Horowitz NS.

Gynecol Oncol. 2012 Jan;124(1):53-8. doi: 10.1016/j.ygyno.2011.09.024. Epub 2011 Oct 26.

PMID:
22032836
13.

A new prognostic index model using meta-analysis in early-stage epithelial ovarian cancer.

Park HJ, Nam EJ, Rha SY, Kim S, Kim SW, Kim JW, Kim YT.

Gynecol Oncol. 2012 Sep;126(3):357-63. doi: 10.1016/j.ygyno.2012.06.006. Epub 2012 Jun 8.

PMID:
22687686
14.

Prognostic importance of intraoperative rupture of malignant ovarian epithelial neoplasms.

Sainz de la Cuesta R, Goff BA, Fuller AF Jr, Nikrui N, Eichhorn JH, Rice LW.

Obstet Gynecol. 1994 Jul;84(1):1-7.

PMID:
8008300
15.

Prognostic factors for early-stage epithelial ovarian cancer, treated with adjuvant carboplatin/paclitaxel chemotherapy: a single institution experience.

Bamias A, Karadimou A, Soupos N, Sotiropoulou M, Zagouri F, Haidopoulos D, Thomakos N, Rodolakis A, Antsaklis A, Dimopoulos MA.

Gynecol Oncol. 2011 Oct;123(1):37-42. doi: 10.1016/j.ygyno.2011.06.033. Epub 2011 Jul 18.

PMID:
21764430
16.

Advances in the management of epithelial ovarian cancer.

Berkenblit A, Cannistra SA.

J Reprod Med. 2005 Jun;50(6):426-38. Review.

PMID:
16050567
17.

Preoperative HE4 expression in plasma predicts surgical outcome in primary ovarian cancer patients: results from the OVCAD study.

Braicu EI, Fotopoulou C, Van Gorp T, Richter R, Chekerov R, Hall C, Butz H, Castillo-Tong DC, Mahner S, Zeillinger R, Concin N, Vergote I, Sehouli J.

Gynecol Oncol. 2013 Feb;128(2):245-51. doi: 10.1016/j.ygyno.2012.11.023. Epub 2012 Nov 21.

PMID:
23178313
18.

Serum sErbB1 and epidermal growth factor levels as tumor biomarkers in women with stage III or IV epithelial ovarian cancer.

Baron AT, Lafky JM, Boardman CH, Balasubramaniam S, Suman VJ, Podratz KC, Maihle NJ.

Cancer Epidemiol Biomarkers Prev. 1999 Feb;8(2):129-37.

19.

Primary versus secondary cytoreduction for epithelial ovarian cancer: a paired analysis of tumour pattern and surgical outcome.

Braicu EI, Sehouli J, Richter R, Pietzner K, Lichtenegger W, Fotopoulou C.

Eur J Cancer. 2012 Mar;48(5):687-94. doi: 10.1016/j.ejca.2011.06.034. Epub 2011 Jul 13.

PMID:
21757333
20.

An analysis of patients with bulky advanced stage ovarian, tubal, and peritoneal carcinoma treated with primary debulking surgery (PDS) during an identical time period as the randomized EORTC-NCIC trial of PDS vs neoadjuvant chemotherapy (NACT).

Chi DS, Musa F, Dao F, Zivanovic O, Sonoda Y, Leitao MM, Levine DA, Gardner GJ, Abu-Rustum NR, Barakat RR.

Gynecol Oncol. 2012 Jan;124(1):10-4. doi: 10.1016/j.ygyno.2011.08.014. Epub 2011 Sep 13.

PMID:
21917306

Supplemental Content

Support Center